Physician profile
Robert A Dawson
NPI 1154393478
$661.27
in general payments reported to CMS, 2019-2025
14 companies · $65.00 in 2025
The $65.00 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $245 · 2022: $119 · 2023: $88.16 · 2024: $145 · 2025: $65.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $197.34 | 2021-2025 | Durolane, Supartz Fx Sodium Hyaluronate |
| Kowa Pharmaceuticals America, INC. | $101.89 | 2022-2023 | Seglentis |
| Pacira Therapeutics, INC. | $91.66 | 2021 | |
| Depuy Synthes Sales INC. | $64.29 | 2021-2024 | Orthovisc, Monovisc |
| Mimedx Group, INC. | $27.08 | 2024 | |
| Heraeus Medical, LLC. | $25.11 | 2022 | |
| Becton, Dickinson and Company | $24.47 | 2024 | Arista Ah Flexitip |
| Avanos Medical | $21.85 | 2021 | |
| Endo USA, INC. | $21.20 | 2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $18.27 | 2021 | |
| Stryker Corporation | $17.80 | 2024 | Inspace |
| Nabriva Therapeutics, Plc | $17.41 | 2021 | |
| Impel Pharmaceuticals INC. | $16.76 | 2022 | |
| Ethicon US, LLC | $16.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dawson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.